PFE  Pfizer Inc.




Consumer Durables


Major Pharmaceuticals

Market Cap.


Vuru Grade


Current Price

+0.20 (+0.62%)

Growth Price

Overvalued by 21.17%

Stability Price

Overvalued by 63.24%

Company Metrics

  • P/E 28.9
  • P/S 3.76
  • P/B 3.13
  • EPS 1.13
  • Cash ROIC 13.13%
  • Cash Ratio 0.79
  • Dividend 1.2 / 3.73%
  • Avg. Vol. 19.15M
  • Shares 6.07B
  • Market Cap. 197.74B

Company Description

Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segment's provides Lipitor for elevated LDL-cholesterol levels in the blood; Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis; Lyrica for post-herpetic neuralgia, diab... more

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


Should You Buy Pfizer Now?
Seeking Alpha - 3 hours ago
Pfizer is capable of achieving strong growth numbers even if the company does not split its business. Uncertainty of taxes related to repatriation of cash from foreign operations is not a company-specific risk in USA. Loss of patent exclusivity ...
Better Buy: Pfizer Inc. vs. GlaxoSmithKline plc
Motley Fool - Oct 20, 2016
Other current products helping Pfizer significantly include smoking cessation drug Chantix/Champix and cancer drug Xalkori.
Pfizer Inks Deal For Medivation Acquisition - The Cerbat Gem
Reg Filings: Mcclain Value Management LLC Holding in Pfizer INC (PFE) Trimmed ...
Chester News - 5 hours ago
Mcclain Value Management Llc decreased its stake in Pfizer Inc. (PFE) by 72.49% based on its latest 2016Q2 regulatory filing with the SEC.
Market Traders Recap - Pfizer Inc.'s (PFE) - Hot Stocks Point
Pfizer Inc. (NYSE:PFE) reported its past quarter results on 02/02/2016 - FactsReporter
Pfizer Divests Hospira Infusion Systems To ICU, Retaining An Interest In The ...
Forbes - Oct 10, 2016
Pfizer Inc. (NYSE: PFE) recently announced that it has entered into definitive agreement with ICU Medical (NASDAQ: ICUI) to sell its infusion systems business, which it had received via the acquisition of Hospira last year.
Stocks Buzz Pfizer Inc. (NYSE:PFE), Vereit Inc (NYSE:VER) - Wall Street 24
Pfizer Becomes Oversold
Forbes - Oct 17, 2016
But making Pfizer Inc an even more interesting and timely stock to look at, is the fact that in trading on Monday, shares of PFE entered into oversold territory, changing hands as low as $32.49 per share.
Pfizer Inc. (PFE) Closes 0.25% Up on the Day for October 27 - 32 minutes ago
Dow Jones component Pfizer Inc. (PFE) saw its stock move 0.25% to $32.48, representing a per-share move of $0.08, on volume of 17.48 million shares for Thursday.
Pfizer Declines Overdone
Seeking Alpha - Oct 24, 2016
Pfizer, Inc. (NYSE:PFE) is a research-oriented global biopharmaceutical company that was established in 1942, and is now headquartered in New York City.
Q4 2016 EPS Estimates for Pfizer Inc. (PFE) Lifted by Leerink Swann - The Cerbat Gem
Position Changed: Advisors Asset Management INC Trimmed Its Pfizer INC (PFE ... - Chester News
Pfizer Inc. (PFE) Shares Bought by Seaward Management Limited Partnership
The Cerbat Gem - Oct 23, 2016
Pfizer logo Seaward Management Limited Partnership raised its stake in shares of Pfizer Inc. (NYSE:PFE) by 5.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
Analysts Concerns on: Pfizer Inc. (NYSE:PFE) - Post Registrar
Pfizer Inc. (PFE) Stake Increased by HL Financial Services LLC - BBNS
Pfizer Inc. (PFE) Closes 0.37% Up on the Day for October 26 - Oct 26, 2016
Dow Jones component Pfizer Inc. (PFE) saw its stock move 0.37% to $32.40, representing a per-share move of $0.12, on volume of 17.1 million shares for Wednesday.
Q4 2016 EPS Estimates for Pfizer Inc. (PFE) Increased by Analyst
Community Financial News - Oct 26, 2016
Pfizer logo Pfizer Inc. (NYSE:PFE) - Equities research analysts at Leerink Swann raised their Q4 2016 earnings estimates for shares of Pfizer in a report released on Thursday.
Pfizer Inc. (PFE) Position Held by Copeland Capital Management LLC - DailyQuint
Pfizer Inc. (NYSE:PFE) & Calpine Corporation (NYSE:CPN) Stocks Buzz - Money News